Table 1 demographic conditions of the study population
From: Point-of-care pancreatic stone protein measurement in critically ill COVID-19 patients
Variable mean ± st.dev or % | Overall | Survivors (13 patients) | Non Survivors (8 patients) | p value |
|---|---|---|---|---|
Age | 69.04 ± 7.63 | 67.69 ± 8.54 | 71.25 ± 5.70 | 0.259 |
SOFA Baseline | 5.28 ± 2.95 | 4.61 ± 4.17 | 6.37 ± 2.32 | 0.145 |
Horowitz index | 142.91 ± 55.91 | 134.15 ± 60.67 | 155.31 ± 47.98 | 0.268 |
Female at birth% | 52.38 | 53.85 | 50.00 | 0.864 |
Hypertension% | 38.10 | 38.46 | 37.50 | 0.965 |
DM II | 23.81 | 23.08 | 25.00 | 0.920 |
CKF | 9.52 | 0.00 | 25.00 | 0.133 |
Atrial Fibrillation | 9.52 | 0.00 | 25.00 | 0.133 |
Others | 38.10% | 30.77 | 50.00 | 0.378 |